VectivBio Holding AG Ordinary Shares
VECT
VECT was delisted on the 7th of July, 2023.
17 hedge funds and large institutions have $110M invested in VectivBio Holding AG Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.19% more ownership
Funds ownership: 68.41% → 68.6% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less capital invested
Capital invested by funds: $114M → $110M (-$4.11M)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
19% less funds holding
Funds holding: 21 → 17 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
CHI Advisors
New York
|
+$2.14M |
| 2 |
O
OrbiMed
New York
|
+$559K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$66.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.56K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$740K |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$723K |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$427K |
| 4 |
PCM
Pinz Capital Management
New York
|
-$295K |
| 5 |
JG
Jefferies Group
New York
|
-$81.7K |
VECT Hedge Fund Activity: Q1 2022 in Review
17 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q1 2022, worth a combined $110M — down 3.6% from $114M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of VECT and 0 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was CHI Advisors, adding an estimated $2.14M. The largest seller was Novo Holdings A/S, cutting an estimated $740K.
- 17 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q1 2022, down from 21 in Q4 2021.
- Funds reported $110M of VectivBio Holding AG Ordinary Shares stock for Q1 2022, down 3.6% quarter-over-quarter.
- 0 funds opened new VectivBio Holding AG Ordinary Shares positions in Q1 2022 and 4 closed out, a net change of -4 holders.
- The largest VectivBio Holding AG Ordinary Shares buyer in Q1 2022 was CHI Advisors, an estimated $2.14M added.
- The largest VectivBio Holding AG Ordinary Shares seller in Q1 2022 was Novo Holdings A/S, an estimated $740K sold.
Based on aggregated 13F filings for Q1 2022.